Oxaliplatin activates P53/miR-34a/survivin axis in inhibiting the progression of gastric cancer cells.

Immun Inflamm Dis · 2024 · PMC11386343 · PMID 39254476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The cell viability showed a decreasing trend in group +34a compared with the C group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.